Denosumab As an Enhancer of the Immune Infiltrate in Hormone Receptor-Positive Early Breast Cancer. Subgroup Analysis from the D-Biomark Window-of-opportunity Clinical Trial (NCT03691311)
CANCER RESEARCH(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined